AIDS
Conditions
Interventions
Test Group:ZL-1 and HARRT
Control Group:ZL-1 placebo and HARRT
Sponsors
Shanghai Public Health Clinical Center
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Diagnosed as HIV/AIDS (according to standard WS293-2008); 2. Participant aged 16 to 60 years old; 3. Accepted ART treatment over 12 months,and HIV-RNA< 50 copies/mL last than 12 months; 4. HIV-RNA < 50 copies/mL and CD4+< 200 cells/uL; 5. Diagnosed as Qi and Yin deficiency syndrome; 6. Attend the study signed the informed consent voluntarily, and complete the visitation.
Exclusion criteria
Exclusion criteria: 1. Severe opportunistic infection or tumors; 2. WBC2×ULN,TBIL>1×ULN,Cr>1×ULN; 3. Received other investigational drugs within 3 months; 4. HbsAg positive,HBV DNA>2000 IU/ml; Anti-HCV positive and HCV RNA positive; 5. Pregnant or breastfeeding women, and refuse to use regular birth control method during the study; 6. Allergic or intolerant to the trial drug; 7. Serious mental and neurological diseases; 8. Alcoholism ,drug addicts; 9. Patients that are inappropriate base on investigators opinion( those are in poor health or cant follow the visit).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percent of patients that CD4+Cells=30%; | — |
Secondary
| Measure | Time frame |
|---|---|
| CD4+/CD8+;HIV-RNA;Symptoms and signs of traditional Chinese Medicine; | — |
Countries
China
Contacts
Public ContactLu Hongzhou
Shanghai Public Health Clinical Center
Outcome results
None listed